Sort
40,608 grants matching “prostate cancer”
Chemical Biology of IRP1-HIF2a Signaling
$601,728Othon Iliopoulos · Massachusetts General Hospital · R01 · FY2019 · CA
Prostate Cancer Studies
$601,704Michael Cook · Division Of Cancer Epidemiology And Genetics · ZIA · FY2015 · CA
Development of fast diffusion magnetic resonance fingerprinting of the prostate to avoid unnecessary biopsies
$601,460Leonardo Kayat Bittencourt · Case Western Reserve University · R01 · FY2025 · CA
Molecular Targets for Cancer Detection and Treatment
$601,428William George Nelson · Johns Hopkins University · T32 · FY2013 · CA
Genetic Epidemiology of Cancer
$601,408Joan E. Bailey-Wilson · National Human Genome Research Institute · ZIA · FY2015 · HG
UNIVERSITY OF ROCHESTER--CCOP RESEARCH BASE
$601,397University Of Rochester · U10 · FY2000 · CA
Targeting the Plk1/Pdcd4/mTORC2 Signaling to Treat Castration-Resistant Prostate Cancer
$601,289Xiaoqi Liu · University Of Kentucky · R01 · FY2024 · CA
Project 3: Spherical Nucleic Acids as Immunotherapeutic Agents for Prostate Cancer
$601,282Chad A. Mirkin · Northwestern University At Chicago · U54 · FY2019 · CA
Breast Cancer PARP PET Imaging AIP to Support FDA Approval & Commercialization
$601,217David A Mankoff · University Of Pennsylvania · R01 · FY2022 · CA
Testing Effective Methods to Recruit Sexual and Gender Minority Cancer Patients for Cancer Studies
$601,214B. R. Simon Rosser · University Of Minnesota · R01 · FY2025 · CA
PROSTATE CANCER CLINICAL TRIALS CONSORTIUM: CLINICAL RESEARCH SITE APPLICATION
$601,182University Of Wisconsin System · · FY2014 · Department of Defense
Primary Project
$601,082Eva M Sevick-Muraca · University Of Texas Hlth Sci Ctr Houston · U54 · FY2010 · CA
Molecular mechanisms underlying lineage plasticity in prostate cancer
$601,022Himisha Beltran · Dana-Farber Cancer Inst · R37 · FY2025 · CA
Centralization of Cancer Care: Implications for Access, Outcomes, and Disparities
$601,009Bruce L. Jacobs · University Of Pittsburgh At Pittsburgh · R37 · FY2025 · CA
Digital Multiplexed Analysis of Circulating Nucleic Acids in Small-Volume Blood Specimens
$600,953Andrew Michael Smith · University Of Illinois At Urbana-Champaign · R01 · FY2025 · EB
An integrative multi-omics approach to characterize prostate cancer risk in diverse populations
$600,909Nicholas Mancuso · University Of Southern California · R01 · FY2022 · CA
CLINICAL TRANSLATION OF HYPERPOLARIZED 13C-UREA FOR CANCER MR MOLECULAR IMAGING
$600,901John Kurhanewicz · University Of California, San Francisco · R01 · FY2021 · CA
Engineered anti-PSCA antibodies for immunoPET and targeted therapy of pancreatic cancer
$600,896Anna M Wu · Beckman Research Institute/City Of Hope · R01 · FY2025 · CA
The Detection, Isolation and Characterization of Disseminated Tumor Cells
$600,861Robert Vessella · University Of Washington · P01 · FY2010 · CA
Commonly Used Medications and Risk of Colorectal Cancer Recurrence
$600,838Jessica Chubak · Kaiser Foundation Health Plan Of Washington · R01 · FY2013 · CA
Defining the epigenetic landscape in human prostate cancer
$600,812Matthew L Freedman · Dana-Farber Cancer Inst · R01 · FY2018 · CA
Targeting Glycogen Metabolism in Ewing's Sarcoma: Diagnostic, Prognostic, and Therapeutic Applications
$600,688Ramon C. Sun · University Of Florida · R01 · FY2024 · CA
The Detection, Isolation and Characterization of Disseminated Tumor Cells
$600,607Robert Vessella · University Of Washington · P01 · FY2009 · CA
Confirmation of SNPs Associated with Aggressive PCa in a GWA Study
$600,462Jianfeng Xu · Wake Forest University Health Sciences · R01 · FY2010 · CA
Identify SNPs and Polymorphisms Involved in the Development of Prostate Cancer
$600,290William Douglas Figg · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA